NDOH circular on Lamivudine
Lamivudine_Stock Availability_040619 (002)
People with HIV are living longer but have fewer years of good health. New guidelines aim to change that
South Africa has an ageing population of people living with HIV. For the first time a set of clinical guidelines maps out a framework to help keep this group of people healthier for longer, reports Elna Schütz.
AIDS 2026: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in
If an HIV prevention pill that provides a month of protection at a time performs well in two ongoing clinical trials, it could become the next big thing in HIV prevention after the lenacapavir injection. A new licensing agreement is paving the way for South Africa’s Aspen Pharmacare to produce the pill should the study findings be positive and the drug be registered.
Positive interim findings on new once-weekly HIV treatment pill
A new antiretroviral combination pill that is taken only once a week appears to work as well as daily pills at treating HIV. This is according to interim study findings to be presented next week at the AIDS 2026 conference in Rio de Janeiro, Brazil.
Leave a Reply